Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period

Acta Neurologica Taiwanica

Volumn 19, Issue 3, 2010, Pages 168-177

  Tu, Min Chien ^a   Huang, Chi Wei ^a   Chen, Nai Ching ^a   Chang, Wen Neng ^a   Lui, Chun Chung ^a   Chen, Chih Feng ^a   Chen, Ching ^a   Wang, Ya Ling ^a   Lin, Yu Ting ^a   Chang, Chiung Chih ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Alzheimer's disease; Cognitive ability screening instrument; Cognitive decline; Homocysteine; White matter hyperintensities

Indexed keywords

CREATININE; HOMOCYSTEINE;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; CHEMICAL ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; RISK FACTOR; THINKING; WHITE MATTER; BLOOD; CASE CONTROL STUDY; MENTAL HEALTH; METHODOLOGY; MIDDLE AGED; MYELINATED NERVE; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES;

EID: 79952478407     PISSN: 10196099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Rosendorff C, Beeri MS, Silverman JM. Cardiovascular risk factors for Alzheimer's disease. Am J Geriatr Cardiol 2007;16:143-149.
2. Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Jolles J, Clarke R, Breteler MM; Rotterdam Scan Study. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002;59:1375-1380. (Pubitemid 35285990)
3. Sachdev P. Homocysteine, cerebrovascular disease and brain atrophy. J Neurol Sci 2004;226:25-29. (Pubitemid 39505400)
4. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483. (Pubitemid 34441738)
5. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683-1689. (Pubitemid 23307935)
6. Meyer JS, Kawamura J, Terayama Y. White matter lesions in the elderly. J Neurol Sci 1992;110:1-7.
7. Duan JH, Wang HQ, Xu J, Lin X, Chen SQ, Kang Z, Yao ZB. White matter damage of patients with Alzheimer's disease correlated with the decreased cognitive function. Surg Radiol Anat 2006;28:150-156.
8. Barber R, Scheltens P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999;67:66-72. (Pubitemid 29278329)
9. Bondareff W, Raval J, Colletti PM, Hauser DL. Quantitative magnetic resonance imaging and the severity of dementia in Alzheimer's disease. Am J Psychiatry 1988;145:853-856.
10. Leys D, Soetaert G, Petit H, Fauquette A, Pruvo JP, Steinling M. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol 1990;47:524-527. (Pubitemid 20155840)
11. van Guldener C, Stam F, Stehouwer CD. Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation. Clin Chem Lab Med 2005;43:1026-1031. (Pubitemid 41581956)
12. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 2008;15:123-132. (Pubitemid 351343871)
13. Liu HC, Chou P, Lin KN, Wang SJ, Fuh JL, Lin HC, Liu CY, Wu GS, Larson EB, White LR. Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol Med 1994;24:763-770. (Pubitemid 24265759)
14. Villareal DT, Grant E, Miller JP, Storandt M, McKeel DW, Morris JC. Clinical outcomes of possible versus probable Alzheimer's disease. Neurology 2003;61:661-667. (Pubitemid 37082604)
15. American Psychiatric Associations Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV), Washington: American Psychiatric Association, 1994.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944. (Pubitemid 14076461)
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572. (Pubitemid 37430158)
18. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488. (Pubitemid 10073130)
19. Lin KN, Wang PN, Liu CY, Chen WT, Lee YC, Liu HC. Cutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia. Dement Geriatr Cogn Disord 2002;14:176-182.
20. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993;50:818-824. (Pubitemid 23229307)
21. Kim SR, Choi SH, Ha CK, Park SG, Pyun HW, Yoon DH. Plasma total homocysteine levels are not associated with medial temporal lobe atrophy, but with white matter changes in Alzheimer's Disease. J Clin Neurol 2009;5:85-90.
22. Targosz-Gajniak M, Siuda J, Ochudło S, Opala G. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease. J Neurol Sci 2009;283:79-82.
23. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 2006;580:2994-3005. (Pubitemid 43744523)
24. Leibovici D, Ritchie K, Ledésert B, Touchon J. Does education level determine the course of cognitive decline? Age Ageing 1996;25:392-397. (Pubitemid 26381772)
25. Nolan KA, Blass JP. Preventing cognitive decline. Clin Geriatr Med 1992;8:19-34.
26. Bengtsson SL, Haynes JD, Sakai K, Buckley MJ, Passingham RE. The representation of abstract task rules in the human prefrontal cortex. Cereb Cortex 2009;19:1929-1936.
27. Papagno C, Fogliata A, Catricalá E, Miniussi C. The lexical processing of abstract and concrete nouns. Brain Res 2009;1263:78-86.
28. Noppeney U, Price CJ. Retrieval of abstract semantics. Neuroimage 2004;22:164-170. (Pubitemid 38515822)
29. Chen TF, Chen YF, Cheng TW, Hua MS, Liu HM, Chiu MJ. Executive dysfunction and periventricular diffusion tensor changes in amnesic mild cognitive impairment and early Alzheimer's disease. Hum Brain Mapp 2009;30:3826-3836.
30. Stricker NH, Schweinsburg BC, Delano-Wood L, Wierenga CE, Bangen KJ, Haaland KY, Frank LR, Salmon DP, Bondi MW. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. Neuroimage 2009;45:10-6.
31. Bigler ED, Lowry CM, Kerr B, Tate DF, Hessel CD, Earl HD, Miller MJ, Rice SA, Smith KH, Tschanz JT, Welsh-Bohmer K, Plassman B, Victoroff J. Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging. Neuropsychology 2003;17:339-352. (Pubitemid 37013145)
32. Devine ME, Fonseca JA, Walker RW, Sikdar T, Stevens T, Walker Z. Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study. Int J Geriatr Psychiatry 2007;22:1120-1126. (Pubitemid 350120661)
33. Henskens LH, Kroon AA, van Oostenbrugge RJ, Gronenschild EH, Hofman PA, Lodder J, de Leeuw PW. Associations of ambulatory blood pressure levels with white matter hyperintensity volumes in hypertensive patients. J Hypertens 2009;27:1446-1452.
34. Shrestha I, Takahashi T, Nomura E, Ohtsuki T, Ohshita T, Ueno H, Kohriyama T, Matsumoto M. Association between central systolic blood pressure, white matter lesions in cerebral MRI and carotid atherosclerosis. Hypertens Res 2009;32:869-874.
35. Tate DF, Jefferson AL, Brickman AM, Hoth KF, Gunstad J, Bramley K, Paul RH, Poppas A, Cohen RA. Regional White Matter Signal Abnormalities and Cognitive Correlates Among Geriatric Patients with Treated Cardiovascular Disease. Brain Imaging Behav 2008;2:200-206.
36. Sala I, Belén Sánchez-Saudinós M, Molina-Porcel L, Lázaro E, Gich I, Clarimón J, Blanco-Vaca F, Blesa R, Gómez-Isla T, Lleó A. Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance. Dement Geriatr Cogn Disord 2008;26:506-512.
37. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 1999;150:283-289. (Pubitemid 29344955)
38. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A 3rd. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005;82:627-635.
39. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, Rosand J, Growdon JH, Greenberg SM. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 2006;66:23-29. (Pubitemid 43739586)
40. Brickman AM, Muraskin J, Zimmerman ME. Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci 2009;11:181-190.
41. Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 2002;59:787-793. (Pubitemid 34517761)
42. Waldemar G, Christiansen P, Larsson HB, Høgh P, Laursen H, Lassen NA, Paulson OB. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. J Neurol Neurosurg Psychiatry 1994;57:1458-1465. (Pubitemid 2163028)